PROTAC_ERRα

N/A

Report date: 2023/03/01 09:50:54
NME

Base Information

Drug NamePROTAC_ERRα
Drug Alias NamePROTAC_ERRαPROTAC-ERRα
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionOrphan nuclear receptors antagonistsvon Hippel-Lindau disease tumor suppressor degraders
TargetsOrphan nuclear receptorsvon Hippel-Lindau disease tumor suppressor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGsk LtdArvinas Inc
China Registration ClassN/A

Develop Information

Active CompaniesArvinas IncGsk Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A